Guerbet Reaffirms 2026 Restated EBITDA Margin Outlook of Around 8%

• Guerbet reaffirmed its 2026 guidance for stable or slightly lower revenue at constant exchange rates on a like-for-like basis.
• The restated EBITDA margin target remains around 8%, including approximately €35 million in Raleigh remediation costs.
• Free cash flow is forecast at negative €50 million to €70 million, reflecting lower restated EBITDA, higher capital expenditure and restructuring costs.
• Nine-month revenue totaled €573.8 million, down 1.3% at constant exchange rates on a like-for-like basis.
• Excluding China, where healthcare market restructuring weighed on sales, nine-month revenue grew 1%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guerbet SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610221145PRIMZONEFULLFEED1001279413) on October 22, 2026, and is solely responsible for the information contained therein.